Latest Insider Transactions at Med Avail Holdings, Inc. (MDVL)
This section provides a real-time view of insider transactions for Med Avail Holdings, Inc. (MDVL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MedAvail Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MedAvail Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Ramona Seabaugh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
303
-19.87%
|
$1,515
$5.7 P/Share
|
|
Sep 01
2023
|
Ramona Seabaugh Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
680
+30.84%
|
-
|
|
Mar 21
2023
|
Ramona Seabaugh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,287
-15.21%
|
$0
$0.31 P/Share
|
|
Mar 06
2023
|
Mark Edward Doerr Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
72,785
-27.84%
|
$0
$0.31 P/Share
|
|
Mar 03
2023
|
Mark Edward Doerr Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,773
-7.36%
|
$0
$0.33 P/Share
|
|
Mar 03
2023
|
Ramona Seabaugh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,727
-23.74%
|
$0
$0.34 P/Share
|
|
Mar 01
2023
|
Mark Edward Doerr Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
282,259
+50.0%
|
-
|
|
Mar 01
2023
|
Ramona Seabaugh Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,333
+45.69%
|
-
|
|
Jul 01
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,639,117
+28.57%
|
$7,639,117
$1.06 P/Share
|
|
Jul 01
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
9,411,765
+21.38%
|
$9,411,765
$1.06 P/Share
|
|
Apr 04
2022
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,117,646
+38.06%
|
$14,117,646
$1.06 P/Share
|
|
Apr 04
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
14,117,646
+35.91%
|
$14,117,646
$1.06 P/Share
|
|
Dec 31
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,670
+0.19%
|
$190,050
$15.0 P/Share
|
|
Dec 29
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100
+0.0%
|
$1,400
$14.0 P/Share
|
|
Dec 28
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,107
+0.11%
|
$92,391
$13.98 P/Share
|
|
Dec 24
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,890
+0.13%
|
$115,570
$13.99 P/Share
|
|
Dec 23
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,700
+0.32%
|
$282,100
$13.99 P/Share
|
|
Dec 22
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,948
+0.25%
|
$220,324
$13.7 P/Share
|
|
Dec 21
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,277
+0.24%
|
$211,601
$13.31 P/Share
|
|
Dec 18
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
18,600
+0.28%
|
$241,800
$13.59 P/Share
|
|
Dec 17
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,954
+0.11%
|
$194,402
$13.56 P/Share
|
|
Dec 16
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,429
+0.43%
|
$369,577
$13.06 P/Share
|
|
Dec 15
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
29,429
+0.22%
|
$353,148
$12.79 P/Share
|
|
Dec 14
2020
|
Abg Wtt Med Avail LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,457
+0.22%
|
$173,484
$12.24 P/Share
|
|
Oct 01
2020
|
Joseph Mannello Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
180,000
+10.3%
|
-
|